DK1883452T3 - Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol - Google Patents

Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol

Info

Publication number
DK1883452T3
DK1883452T3 DK06755932.8T DK06755932T DK1883452T3 DK 1883452 T3 DK1883452 T3 DK 1883452T3 DK 06755932 T DK06755932 T DK 06755932T DK 1883452 T3 DK1883452 T3 DK 1883452T3
Authority
DK
Denmark
Prior art keywords
carvacrol
thymol
eugenol
pharmaceutical composition
composition containing
Prior art date
Application number
DK06755932.8T
Other languages
English (en)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Application granted granted Critical
Publication of DK1883452T3 publication Critical patent/DK1883452T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06755932.8T 2005-05-13 2006-05-15 Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol DK1883452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
PCT/IB2006/001441 WO2006120568A2 (fr) 2005-05-13 2006-05-15 Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone

Publications (1)

Publication Number Publication Date
DK1883452T3 true DK1883452T3 (da) 2013-02-25

Family

ID=35427309

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06755932.8T DK1883452T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol
DK06744739.1T DK1879656T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06744739.1T DK1879656T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol

Country Status (16)

Country Link
US (2) US20080171768A1 (da)
EP (2) EP1883452B1 (da)
JP (1) JP5073651B2 (da)
CN (2) CN101193682B (da)
AP (1) AP2437A (da)
AT (1) ATE554827T1 (da)
BR (2) BRPI0610130A2 (da)
CA (2) CA2606887C (da)
DK (2) DK1883452T3 (da)
EA (1) EA015168B1 (da)
ES (2) ES2386292T3 (da)
MA (2) MA29573B1 (da)
PT (2) PT1883452E (da)
TN (2) TNSN07423A1 (da)
WO (3) WO2006120495A1 (da)
ZA (1) ZA200710785B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
EA019746B1 (ru) 2009-09-24 2014-05-30 Юнилевер Нв Противомикробная композиция, содержащая эвгенол, терпинеол и тимол, и способ дезинфицирования поверхности
EA022986B1 (ru) 2010-12-07 2016-04-29 Юнилевер Нв Композиция для ухода за полостью рта
CN103998011B (zh) 2011-11-03 2016-11-23 荷兰联合利华有限公司 个人清洁组合物
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
US20180078515A1 (en) * 2015-03-20 2018-03-22 Sammy Oyoo OPIYO Use of suramin and arginase inhibitors in malignant neoplasia
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
JP7033586B2 (ja) 2016-06-02 2022-03-10 アドバンスト サイエンティフィック ディヴェロップメンツ シネオールとアモキシシリンとを含む医薬製剤
BR112019020225A2 (pt) * 2017-03-28 2020-04-22 IRP Health Pty Ltd alcaloides berberina na prevenção e/ou tratamento de doença intestinal
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2000033858A1 (en) * 1998-12-07 2000-06-15 Ecosmart Technologies, Inc. Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2002227913B2 (en) * 2000-11-09 2007-08-02 Jorg P. Schur Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
US20040092583A1 (en) * 2001-01-02 2004-05-13 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
ATE478684T1 (de) * 2002-02-20 2010-09-15 Ninkov Dusan Dr Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004052308A2 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
EP1879656A1 (fr) 2008-01-23
CA2606887A1 (fr) 2006-11-16
US20080171768A1 (en) 2008-07-17
ZA200710785B (en) 2009-06-24
PT1879656E (pt) 2012-07-25
TNSN07426A1 (fr) 2009-03-17
DK1879656T3 (da) 2012-07-23
CA2608061A1 (fr) 2006-11-16
JP2008540505A (ja) 2008-11-20
CN101193682A (zh) 2008-06-04
ATE554827T1 (de) 2012-05-15
CA2608061C (fr) 2014-07-15
TNSN07423A1 (fr) 2009-03-17
JP5073651B2 (ja) 2012-11-14
CN101193682B (zh) 2012-06-13
EA015168B1 (ru) 2011-06-30
ES2399348T3 (es) 2013-03-27
EP1883452A2 (fr) 2008-02-06
WO2006120564A1 (fr) 2006-11-16
CA2606887C (fr) 2014-07-15
MA29573B1 (fr) 2008-06-02
WO2006120568A3 (fr) 2007-08-23
EA200702486A1 (ru) 2008-06-30
CN101175532B (zh) 2011-12-28
BRPI0610130A2 (pt) 2012-09-25
ES2386292T3 (es) 2012-08-16
AP2437A (en) 2012-08-31
PT1883452E (pt) 2013-02-18
EP1879656B1 (fr) 2012-04-25
EP1883452B1 (fr) 2012-12-19
CN101175532A (zh) 2008-05-07
BRPI0610123A2 (pt) 2012-09-25
MA29908B1 (fr) 2008-11-03
AP2007004228A0 (en) 2007-12-31
WO2006120495A1 (fr) 2006-11-16
US20080171709A1 (en) 2008-07-17
WO2006120568A2 (fr) 2006-11-16

Similar Documents

Publication Publication Date Title
DK1883452T3 (da) Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol
DK1879654T3 (da) Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol
BRPI0810552A2 (pt) Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa.
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
DK1940459T3 (da) Fast-opløsningsperforator indeholdende aktivstofpartikel og/eller aktivstof-adsorberede partikler
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
DK1890681T3 (da) Törgranuleret sammensætning indeholdende emtricitabin og tenofovir DF
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
PT1879655E (pt) Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol
IL218840A0 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
DK1939204T3 (da) Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf
DK1901731T3 (da) Niacinreceptoragonister, sammensætninger indeholdende sådanne forbindelser og fremgangsmåder til behandling
BRPI0814891A2 (pt) Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo.
CU23779B7 (es) Compuestos de pirazolina y su uso y composiciones farmacéuticas
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
BRPI0820673A2 (pt) Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal
BRPI0907650A2 (pt) Composições farmacêuticas compreendendo degradadores de produtos finais de glicosilação avançada (ages) e drogas adjuvantes como drogas anti-hipertensivas, antidiabéticas e etc
BRPI0821373A2 (pt) Composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
DK1745786T3 (da) Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem
BRPI0820985A2 (pt) Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos
DK1707564T3 (da) Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
DK2024329T3 (da) (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas